The molecular mechanisms that underlie the immune biology of anti-drug antibody formation following treatment with monoclonal antibodies

A Vaisman-Mentesh, M Gutierrez-Gonzalez… - Frontiers in …, 2020 - frontiersin.org
Monoclonal antibodies (mAbs) are a crucial asset for human health and modern medicine,
however, the repeated administration of mAbs can be highly immunogenic. Drug …

Class II MHC antigen processing in immune tolerance and inflammation

MM Jurewicz, LJ Stern - Immunogenetics, 2019 - Springer
Presentation of peptide antigens by MHC-II proteins is prerequisite to effective CD4 T cell
tolerance to self and to recognition of foreign antigens. Antigen uptake and processing …

Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes

J Racle, J Michaux, GA Rockinger, M Arnaud… - Nature …, 2019 - nature.com
Predictions of epitopes presented by class II human leukocyte antigen molecules (HLA-II)
have limited accuracy, restricting vaccine and therapy design. Here we combined unbiased …

Predicting HLA CD4 immunogenicity in human populations

SK Dhanda, E Karosiene, L Edwards, A Grifoni… - Frontiers in …, 2018 - frontiersin.org
Background Prediction of T cell immunogenicity is a topic of considerable interest, both in
terms of basic understanding of the mechanisms of T cells responses and in terms of …

[HTML][HTML] HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation

ED Mellins, LJ Stern - Current opinion in immunology, 2014 - Elsevier
Highlights•Two recent crystal structures show how DM interacts with MHCII proteins.•Studies
of H2-O knockout mice reveal a role for DO in regulating immunity and autoimmunity.•Key …

Protective HLA alleles against severe COVID-19: HLA-A* 68 as an ancestral protection allele in Tapachula-Chiapas, Mexico

S Hernández-Doño, RA Sánchez-González… - Clinical …, 2022 - Elsevier
HLA is a polymorphic antigen presenter which has provided valuable information on the
susceptibility of populations to viruses. Therefore, the study of HLA can reveal specific …

Identification of distinct immune cell subsets associated with asymptomatic infection, disease severity, and viral persistence in COVID-19 patients

X Wang, H Bai, J Ma, H Qin, Q Zeng, F Hu… - Frontiers in …, 2022 - frontiersin.org
The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection
remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that …

Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide–MHC complexes

LM Hellman, L Yin, Y Wang, SJ Blevins, TP Riley… - Journal of …, 2016 - Elsevier
Measurements of thermal stability by circular dichroism (CD) spectroscopy have been widely
used to assess the binding of peptides to MHC proteins, particularly within the structural …

Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products

L Yin, X Chen, P Vicini, B Rup, TP Hickling - Cellular Immunology, 2015 - Elsevier
Therapeutic protein products (TPPs) are of considerable value in the treatment of a variety of
diseases, including cancer, hemophilia, and autoimmune diseases. The success of TPP …

[HTML][HTML] A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design

S Sengupta, J Zhang, MC Reed, J Yu… - The Journal of …, 2023 - ncbi.nlm.nih.gov
Distinct CD4+ T cell epitopes have been associated with spontaneous control of HIV-1
replication, but analysis of antigen-dependent factors that influence epitope selection is …